Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMYMP) Operating Expenses (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Operating Expenses for 17 consecutive years, with $11.0 billion as the latest value for Q4 2025.

  • Quarterly Operating Expenses fell 9.33% to $11.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $38.9 billion through Dec 2025, down 31.43% year-over-year, with the annual reading at $38.9 billion for FY2025, 31.43% down from the prior year.
  • Operating Expenses for Q4 2025 was $11.0 billion at Bristol Myers Squibb, up from $9.1 billion in the prior quarter.
  • The five-year high for Operating Expenses was $23.4 billion in Q1 2024, with the low at $8.2 billion in Q1 2025.
  • Average Operating Expenses over 5 years is $10.4 billion, with a median of $9.9 billion recorded in 2022.
  • The sharpest move saw Operating Expenses skyrocketed 172.92% in 2024, then tumbled 64.8% in 2025.
  • Over 5 years, Operating Expenses stood at $10.1 billion in 2021, then decreased by 5.73% to $9.5 billion in 2022, then grew by 2.68% to $9.8 billion in 2023, then rose by 24.12% to $12.2 billion in 2024, then dropped by 9.33% to $11.0 billion in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $11.0 billion, $9.1 billion, and $10.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.